Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, July 20, 2016
[ Wed, Jul 20th 2016
] - WOPRAI
[ Wed, Jul 20th 2016
] - WOPRAI
Tue, July 19, 2016
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
[ Tue, Jul 19th 2016
] - WOPRAI
Mon, July 18, 2016
[ Mon, Jul 18th 2016
] - WOPRAI
[ Mon, Jul 18th 2016
] - WOPRAI
[ Mon, Jul 18th 2016
] - WOPRAI
[ Mon, Jul 18th 2016
] - WOPRAI
[ Mon, Jul 18th 2016
] - WOPRAI
David Amsellem Downgraded (SUPN) to Hold on, Jul 18th, 2016
David Amsellem of Piper Sandler, Downgraded "Supernus Pharmaceuticals, Inc." (SUPN) to Hold on, Jul 18th, 2016.
David has made no other calls on SUPN in the last 4 months.
There is 1 other peer that has a rating on SUPN. Out of the 1 peers that are also analyzing SUPN, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- David Steinberg of "Jefferies" Maintained at Strong Buy with Increased Target to $23 on, Thursday, May 12th, 2016
